Gilles Guillemin is a CORE Professor at Macquarie University and the Co-Director of the newly created "MND and Neurodegenerative diseases Research Centre" at the same institution. He is an Honorary Associate of the University of Sydney and the Visiting Senior Research Fellow at The Australasian Research Institute, Sydney Adventist Hospital, Wahroonga. Prof Guillemin has published over 110 papers and edited a book, “Neuroanatomie fonctionnelle: La cellule microgliale”. He has also contributed to 12 other books and presented at over 90 conferences.
Dr Guillemin is heavily involved in tryptophan research, as his group is one of the world’s leading research groups working on neuroactive metabolites derived from tryptophan. He is the newly elected President of both the International Society for Tryptophan Research (ISTRY) and the Neurotoxicity Society (NTS). His current research interest is studying the involvement of tryptophan catabolism (via the kynurenine pathway) in human neurodegenerative diseases such as amyotrophic lateral sclerosis, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease and brain tumours.
The Role of the Editor in Chief
The editor in chief is responsible for editorial decision-making on papers submitted to the journal. The editor in chief is also responsible for editorial matters that include but are not limited to journal supplements, the journal's aims and scope, the editorial board and volunteer peer reviewer pool, editorial assessment of video abstracts, assignment to published papers of endorsements, and for consulting on pre-submission inquiries from authors.